BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38090808)

  • 1. Evolving Treatment Paradigms for Low-Risk Ductal Carcinoma In Situ: Imaging Needs.
    Nguyen DL; Greenwood HI; Rahbar H; Grimm LJ
    AJR Am J Roentgenol; 2024 Mar; 222(3):e2330503. PubMed ID: 38090808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal Carcinoma in Situ: State-of-the-Art Review.
    Grimm LJ; Rahbar H; Abdelmalak M; Hall AH; Ryser MD
    Radiology; 2022 Feb; 302(2):246-255. PubMed ID: 34931856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal Carcinoma In Situ - Quo Vadis?
    Peltecu G
    Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis.
    Ploumen RAW; de Mooij CM; Gommers S; Keymeulen KBMI; Smidt ML; van Nijnatten TJA
    Eur Radiol; 2023 Aug; 33(8):5423-5435. PubMed ID: 37020070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
    Grimm LJ; Neely B; Hou R; Selvakumaran V; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Devalapalli A; Kim C; Soo MS; Hyslop T; Hwang ES; Lo JY
    AJR Am J Roentgenol; 2021 Apr; 216(4):903-911. PubMed ID: 32783550
    [No Abstract]   [Full Text] [Related]  

  • 6. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
    Grimm LJ; Ghate SV; Hwang ES; Soo MS
    Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
    Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
    Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?
    Graña-López L; Herranz M; Domínguez-Prado I; Argibay S; Villares Á; Vázquez-Caruncho M
    Eur Radiol; 2020 Jan; 30(1):514-522. PubMed ID: 31375867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal Carcinoma In Situ Biology, Language, and Active Surveillance: A Survey of Breast Radiologists' Knowledge and Opinions.
    Grimm LJ; Destounis SV; Rahbar H; Soo MS; Poplack SP
    J Am Coll Radiol; 2020 Oct; 17(10):1252-1258. PubMed ID: 32278849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.
    Lynge E; Ponti A; James T; Májek O; von Euler-Chelpin M; Anttila A; Fitzpatrick P; Frigerio A; Kawai M; Scharpantgen A; Broeders M; Hofvind S; Vidal C; Ederra M; Salas D; Bulliard JL; Tomatis M; Kerlikowske K; Taplin S;
    Eur J Cancer; 2014 Jan; 50(1):185-92. PubMed ID: 24041876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current approach and future perspective for ductal carcinoma in situ of the breast.
    Kanbayashi C; Iwata H
    Jpn J Clin Oncol; 2017 Aug; 47(8):671-677. PubMed ID: 28486668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?
    Théberge I; Vandal N; Guertin MH; Perron L
    Breast Cancer Res Treat; 2019 Apr; 174(2):525-535. PubMed ID: 30564969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ductal carcinoma in situ].
    Skaar M; Langhans L; Mertz B; Kroman N
    Ugeskr Laeger; 2018 Sep; 180(38):. PubMed ID: 30259839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of ductal carcinoma in-situ from benign micro-calcifications by dedicated breast computed tomography.
    Aminololama-Shakeri S; Abbey CK; Gazi P; Prionas ND; Nosratieh A; Li CS; Boone JM; Lindfors KK
    Eur J Radiol; 2016 Jan; 85(1):297-303. PubMed ID: 26520874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma.
    Lee J; Jung JH; Kim WW; Park CS; Lee RK; Kim HJ; Kim WH; Park HY
    BMC Cancer; 2020 Sep; 20(1):934. PubMed ID: 32993586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-risk DCIS. What is it? Observe or excise?
    Pinder SE; Thompson AM; Wesserling J
    Virchows Arch; 2022 Jan; 480(1):21-32. PubMed ID: 34448893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinics in diagnostic imaging (180). Ductal carcinoma in situ (DCIS).
    Tan EJ; Moey T; Madhukumar P; Leong LC
    Singapore Med J; 2017 Oct; 58(10):585-592. PubMed ID: 29119195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
    Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
    Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.